Our top pick for
Building a portfolio
Viveve Medical, Inc is a medical devices business based in the US. Viveve Medical shares (VIVE) are listed on the NASDAQ and all prices are listed in US Dollars. Viveve Medical employs 42 staff and has a trailing 12-month revenue of around USD$5.5 million.
|52-week range||USD$2.54 - USD$8|
|50-day moving average||USD$3.3449|
|200-day moving average||USD$4.3844|
|Wall St. target price||USD$9.63|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||USD$-113.927|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Valuing Viveve Medical stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Viveve Medical's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Viveve Medical's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 0x. In other words, Viveve Medical shares trade at around 0x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
|Revenue TTM||USD$5.5 million|
|Gross profit TTM||USD$296,000|
|Return on assets TTM||-53.02%|
|Return on equity TTM||-183.29%|
|Market capitalisation||USD$32 million|
TTM: trailing 12 months
There are currently 2.1 million Viveve Medical shares held short by investors – that's known as Viveve Medical's "short interest". This figure is 0.3% up from 2.1 million last month.
There are a few different ways that this level of interest in shorting Viveve Medical shares can be evaluated.
Viveve Medical's "short interest ratio" (SIR) is the quantity of Viveve Medical shares currently shorted divided by the average quantity of Viveve Medical shares traded daily (recently around 1.3 million). Viveve Medical's SIR currently stands at 1.62. In other words for every 100,000 Viveve Medical shares traded daily on the market, roughly 1620 shares are currently held short.
However Viveve Medical's short interest can also be evaluated against the total number of Viveve Medical shares, or, against the total number of tradable Viveve Medical shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Viveve Medical's short interest could be expressed as 0.2% of the outstanding shares (for every 100,000 Viveve Medical shares in existence, roughly 200 shares are currently held short) or 0.1995% of the tradable shares (for every 100,000 tradable Viveve Medical shares, roughly 200 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Viveve Medical.
Find out more about how you can short Viveve Medical stock.
We're not expecting Viveve Medical to pay a dividend over the next 12 months.
Viveve Medical's shares were split on a 1:10 basis on 1 December 2020. So if you had owned 10 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Viveve Medical shares – just the quantity. However, indirectly, the new 900% higher share price could have impacted the market appetite for Viveve Medical shares which in turn could have impacted Viveve Medical's share price.
Over the last 12 months, Viveve Medical's shares have ranged in value from as little as $2.54 up to $8. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Viveve Medical's is 0.5979. This would suggest that Viveve Medical's shares are less volatile than average (for this exchange).
Viveve Medical, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices for the non-invasive treatment of vaginal introital laxity, sexual function, vaginal rejuvenation, and stress urinary incontinence. The company offers Viveve System comprises of the radiofrequency generator, reusable handpiece, and treatment tip, as well as cryogen canister and other consumable components. It markets its products through sales employees and distributors in the United States, Canada, the Asia Pacific, Europe, the Middle East, Latin America, and internationally. The company was founded in 2005 and is headquartered in Englewood, Colorado.
Steps to owning and managing PNRG, with 24-hour and historical pricing before you buy.
Steps to owning and managing PINC, with 24-hour and historical pricing before you buy.
Steps to owning and managing POAI, with 24-hour and historical pricing before you buy.
Steps to owning and managing PBTS, with 24-hour and historical pricing before you buy.
Steps to owning and managing PTMN, with 24-hour and historical pricing before you buy.
Steps to owning and managing BPOP, with 24-hour and historical pricing before you buy.
Steps to owning and managing PLYA, with 24-hour and historical pricing before you buy.
Steps to owning and managing PAGP, with 24-hour and historical pricing before you buy.
Steps to owning and managing PAA, with 24-hour and historical pricing before you buy.
Steps to owning and managing PSACU, with 24-hour and historical pricing before you buy.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.